Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Chemotherapy +/- G-CSF in Operable Osteosarcoma
NCT00002539Phase 3Completed
- Sponsor
- European Organisation for Research and Treatment of Cancer
- Start
- Aug 1993
- Primary completion
- Oct 2002
- Modality
- Cytokines & Interferons
- Countries
- 8
01
Overview
Phase 3, randomised trial of filgrastim in osteosarcoma (OS) (2 arms), sponsored by European Organisation for Research and Treatment of Cancer. Primary endpoints: Overall Survival and Disease-Free Survival. Started Aug 1993; status: completed.
02
Drugs
filgrastim
03
Conditions
osteosarcoma (OS)
Beyond the preview
Go deeper on NCT00002539.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00002539.